Sei Investments CO Harmony Biosciences Holdings, Inc. Transaction History

Sei Investments CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $636,134 - $1.12 Million	-33,132 Reduced 77.21%	9,779 $315,000
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $1.16 Million - $1.42 Million	-36,273 Reduced 45.81%	42,911 $1.41 Million
Q2 2023 Aug 11, 2023	SELL	$30.5 - $37.4 $364,170 - $446,556	-11,940 Reduced 13.1%	79,184 $2.79 Million
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $707,907 - $1.24 Million	22,984 Added 33.73%	91,124 $2.98 Million
Q4 2022 Feb 10, 2023	SELL	$45.4 - $60.91 $970,107 - $1.3 Million	-21,368 Reduced 23.87%	68,140 $3.75 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $804,229 - $1.06 Million	19,121 Added 27.17%	89,508 $3.97 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $347,440 - $540,221	-10,359 Reduced 12.83%	70,387 $3.46 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $757,315 - $1.17 Million	22,852 Added 39.47%	80,746 $3.93 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $198,540 - $255,731	-5,824 Reduced 9.14%	57,894 $2.47 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $1.64 Million - $2.46 Million	63,718 New	63,718 $2.44 Million

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.05B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.